Interfaith Center on Corporate Responsibility: Shareholders Renew Their Campaign to Curb Escalating Drug Prices at U.S. Drug Makers
November 14, 2019
November 14, 2019
NEW YORK, Nov. 14 -- The Interfaith Center on Corporate Responsibility issued the following news release:
* * *
- 2020 Shareholder Proposals at AbbVie, Amgen, Biogen Eli Lilly and Pfizer Ask for Study to Determine Feasibility of Incorporating Drug Pricing Risks into Exec Incentive Structures.
* * *
Shareholder members of the Interfaith Center on Corporate Responsibility announced that they have filed proposals for the 2020 proxy related to drug . . .
* * *
- 2020 Shareholder Proposals at AbbVie, Amgen, Biogen Eli Lilly and Pfizer Ask for Study to Determine Feasibility of Incorporating Drug Pricing Risks into Exec Incentive Structures.
* * *
Shareholder members of the Interfaith Center on Corporate Responsibility announced that they have filed proposals for the 2020 proxy related to drug . . .